Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$598.03 USD
-17.66 (-2.87%)
Updated Aug 5, 2024 04:00 PM ET
Pre-Market: $599.03 +1.00 (0.17%) 9:22 AM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$598.03 USD
-17.66 (-2.87%)
Updated Aug 5, 2024 04:00 PM ET
Pre-Market: $599.03 +1.00 (0.17%) 9:22 AM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Top Stock Reports for Facebook, Thermo Fisher & McDonalds
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Thermo Fisher Scientific (TMO) and McDonalds (MCD).
Thermo Fisher Grows on Coronavirus Diagnostic Tests Amid Crisis
by Zacks Equity Research
Thermo Fisher (TMO) is optimistic about ramped up production for its COVID-19 diagnostic test to meet growing global demand.
The Zacks Analyst Blog Highlights: Procter & Gamble, Eli Lilly, Thermo Fisher Scientific, Costco Wholesale and Shopify
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, Eli Lilly, Thermo Fisher Scientific, Costco Wholesale and Shopify
5 Stocks to Tap the Nanotechnology Market Boom
by Sreoshi Bera
Given the current scenario, researchers are focusing on nanotechnology as it may offer valuable solutions for COVID-19.
Top Analyst Reports for Procter & Gamble, Eli Lilly & Thermo Fisher
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), Eli Lilly (LLY) and Thermo Fisher Scientific (TMO).
Danaher's (DHR) Product Offerings to Aid Amid Pandemic Scares
by Zacks Equity Research
Danaher's (DHR) risks from pandemic-related uncertainties are evident from weak sales projections for the second quarter. Demand for acute care diagnostics' related products might aid results.
Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.
Thermo Fisher (TMO) Partners With CSL to Expand Pharma Arm
by Zacks Equity Research
Thermo Fisher (TMO), through its alliance with CSL, expands Pharma Services arm to meet the rising demand for biologic therapies.
Why Is Thermo Fisher (TMO) Up 4.8% Since Last Earnings Report?
by Zacks Equity Research
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: SAP, Thermo Fisher, TOTAL, 3M and FIS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SAP, Thermo Fisher, TOTAL, 3M and FIS
Top Stock Analyst Reports for SAP, Thermo Fisher & TOTAL
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Thermo Fisher Scientific (TMO) and TOTAL (TOT).
Thermo Fisher (TMO) Q1 Earnings Top, Life Sciences Sales Grow
by Zacks Equity Research
On coronavirus-led global supply chain disruption, Thermo Fisher (TMO) records a decline in its quarterly Analytical Instruments revenues.
Thermo Fisher Scientific (TMO) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 5.38% and 0.38%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Coronavirus Makes Biotech ETFs Red Hot
by Sweta Killa
The biotech space of the broader healthcare sector is currently the hottest of all segments buoyed by the COVID-19 pandemic.
Will Coronavirus Test Aid Thermo Fisher's (TMO) Q1 Earnings?
by Zacks Equity Research
Thermo Fisher (TMO) successfully attains EUA from the FDA as well as receives the CE Mark in Europe for its COVID-19 diagnostic test.
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amazon (AMZN) to Boost Worker Safety With Testing Lab Facility
by Zacks Equity Research
Amazon (AMZN) to build coronavirus testing lab to ensure safety of its workers.
Here's Why You Should Hold on to Thermo Fisher (TMO) for Now
by Zacks Equity Research
Investors continue to be optimistic about Thermo Fisher (TMO) on its strong segmental growth in the fourth quarter of 2019.
These Medical ETFs & Stocks Deserve a Salute on Health Day
by Sanghamitra Saha
The World Health Day of 2020 puts these medical companies and the related stocks and ETFs in focus.
Amazon (AMZN) in Talks With Test Makers to Screen Workers
by Zacks Equity Research
Amazon (AMZN) is in contact with Abbott Laboratories and Thermo Fisher Scientific to introduce coronavirus testing at its warehouses.
Healthcare Stocks & ETFs to Gain on Coronavirus Test Progress
by Sweta Jaiswal, FRM
It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols, resource allocation and drafting the right healthcare policies.
Coronavirus Hits S&P 500: 4 MedTech Stocks That Fared Better
by Zacks Equity Research
Here are a few MedTech companies which have outperformed the S&P 500 index in the past two months.
Can Economic Stimulus Save MedTech From Coronavirus Doldrums?
by Trina Mukherjee
Following the announcement of the agreement to pass the historic stimulus bill, we look into four MedTech stocks that stand to gain from the same.
Healthcare ETFs Gain on Rising Demand for COVID-19 Tests
by Sweta Jaiswal, FRM
A growing demand for COVID-19 tests has indulged major healthcare place in the race to develop competent testing kits.
4 Stocks Countering Coronavirus Battle With Testing Kits
by Urmimala Biswas
While the market bloodbath is showing no signs of dissipating any time soon, investors might keep an eye on certain genetic testing and medical device companies.